Evidence map›Paper›PMID 25682159›Full record

ArticleBiomaterials2015

Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging.

Guojun Chen, Liwei Wang, Travis Cordie, Corinne Vokoun, Kevin W Eliceiri, Shaoqin Gong

Abstract read
In one paragraph

Article in Biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guojun ChenMaterials Science Program, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institutes for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA.
Liwei WangWisconsin Institutes for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA.
Travis CordieDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA.
Corinne VokounLaboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison, Madison, WI 53706, USA.
Kevin W EliceiriLaboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison, Madison, WI 53706, USA.
Shaoqin GongMaterials Science Program, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institutes for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53792, USA. Electronic address: sgong@engr.wisc.edu.

Funding

Targeted Therapy of Neuroendocrine Cancers Via the Notch Signaling PathwayK25CA166178 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GONG, SHAOQIN - · 2013 to 2017
$994k
NCI NIH HHS 1K25CA166178NCI NIH HHS K25 CA166178
6 · The paper itself

Abstract

A novel type of self-fluorescent unimolecular micelle nanoparticle (NP) formed by multi-arm star amphiphilic block copolymer, Boltron® H40 (H40, a 4th generation hyperbranched polymer)-biodegradable photo-luminescent polymer (BPLP)-poly(ethylene glycol) (PEG) conjugated with cRGD peptide (i.e., H40-BPLP-PEG-cRGD) was designed, synthesized, and characterized. The hydrophobic BPLP segment was self-fluorescent, thereby making the unimolecular micelle NP self-fluorescent. cRGD peptides, which can effectively target αvβ3 integrin-expressing tumor neovasculature and tumor cells, were selectively conjugated onto the surface of the micelles to offer active tumor-targeting ability. This unique self-fluorescent unimolecular micelle exhibited excellent photostability and low cytotoxicity, making it an attractive bioimaging probe for NP tracking for a variety of microscopy techniques including fluorescent microscopy, confocal laser scanning microscopy (CLSM), and two-photon microscopy. Moreover, this self-fluorescent unimolecular micelle NP also demonstrated excellent stability in aqueous solutions due to its covalent nature, high drug loading level, pH-controlled drug release, and passive and active tumor-targeting abilities, thereby making it a promising nanoplatform for targeted cancer theranostics.

Indexed as

Drug Delivery SystemsMicellesCell Line, TumorDrug CarriersHumansHydrodynamicsHydrogen-Ion ConcentrationIntegrin alphaVbeta3Magnetic Resonance SpectroscopyMicroscopy, FluorescenceNeovascularization, PathologicOligopeptidesPeptidesPhotonsPolyethylene GlycolsPolymersarginyl-glycyl-aspartic acidDrug CarriersIntegrin alphaVbeta3MicellesOligopeptidesPeptidesPolyethylene GlycolsPolymersBioimaging probeCancer theranosticsDrug deliveryDrug nanocarrierSelf-fluorescenceUnimolecular micelles

Identifiers

PMID25682159
PMCPMC4329508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.